• Isabela Bispo Santos da Silva Costa, Cristina Salvadori Bittar, Stephanie Itala Rizk, Antônio Everaldo de Araújo Filho, Karen Alcântara Queiroz Santos, Theuran Inahja Vicente Machado, Fernanda Thereza de Almeida Andrade, Thalita Barbosa González, Andrea Nataly Galarza Arévalo, Almeida Juliano Pinheiro de JP Universidade de São Paulo - Instituto do Câncer do Estado de São Paulo, São Paulo, SP - Brasil., Fernando Bacal, Oliveira Gláucia Maria Moraes de GMM 0000-0002-0737-6188 Universidade Federal do Rio de Janeiro - Cardiologia, Rio de Janeiro, RJ - Brasil., Lacerda Marcus Vinícius Guimarães de MVG Fundação de Medicina Tropical Doutor Heitor Vieira Dourado, Manaus, AM - Brasil., Silvio Henrique Barberato, Antonio Carlos Palandri Chagas, Carlos Eduardo Rochitte, Ramires José Antonio Franchini JAF Universidade de São Paulo Instituto do Coração, São Paulo, SP - Brasil., Roberto Kalil Filho, and Ludhmila Abrahão Hajjar.
• Universidade de São Paulo - Instituto do Câncer do Estado de São Paulo, São Paulo, SP - Brasil.
• Arq. Bras. Cardiol. 2020 May 11; 114 (5): 805-816.

AbstractIn face of the pandemic of the novel coronavirus disease 2019 (COVID-19), the management of patients with cardiovascular risk factors and/or disease is challenging. The cardiovascular complications evidenced in patients with COVID-19 derive from several mechanisms, ranging from direct viral injury to complications secondary to the inflammatory and thrombotic responses to the infection. The proper care of patients with COVID-19 requires special attention to the cardiovascular system aimed at better outcomes.

31 keywords...

hide…